Increasing prevalence of Infectious diseases such as Influenza, HPV, Hepatitis, HIV and Tuberculosis despite rise in sanitation practices globally. In the past, antimicrobials medicines were used to fight powerful infectious disease but slowly in today's time antimicrobial agent is not able to give the desired results because the problem of drug resistant occurs in many people across the world. Nowadays, a new diagnostic procedure is being followed to fight infectious disease like molecular diagnostic test is very effective which is quite fast and precise. The number of cancer patients is increasing very fast, so it is believed that in the coming time the molecular diagnostic test market will be growing at rapid pace. Global Molecular Diagnostics Market is likely to surpass US$ 22.5 Billion by the end of year 2025.
There are various reasons that will propel the market growth in forecast year; rising incidence rate of infectious disease, increasing incidence rate of cancer of all type, increasing people awareness regarding molecular diagnostic, rapid technological growth, widely acceptance of personalized medicine, rising healthcare infrastructure, increasing healthcare per capita expenditure across the developed and developing nation, accuracy of diagnosis, growing population of cardiovascular and neurological disorder etc. In addition, increasing prevalence of genetic disorder will further boost the market in forecast period of time.
Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=global-molecular-diagnostics-market-and-future-forecast-2010-2014-334-p.php
Renub Research report titled “Molecular Diagnostics Market Share & Forecast, By Application (Infectious Diseases, Blood Screening, Oncology, Genetic Testing, HLA (Tissue Typing), Microbiology, Cardiovascular Diseases, Neurological Diseases, Pharmacogenomics and Others), By Technology (PCR, Transcription-Mediated Amplification (TMA), Hybridiazation (In-situ Hybridiazation & FISH), DNA Sequencing & NGS, Microarray and Others), By End User (Hospitals & Academic Laboratories, Clinics and Commercial Laboratories, Others), By Regions [United States, Europe (Expect Russia), India, China, Japan, Brazil, South Korea, Mexico, Russia and ROW], Companies (Roche, Abbott, Myriad Genetics, Qiagen, BioMérieux and Others)” provides a complete analysis of Molecular Diagnostics Market.
Market Insight by Application
The report provides comprehensive analysis of molecular diagnostic test market by application into ten parts: Infectious Diseases, Genetic Testing, Blood Screening, Oncology, HLA (Tissue Typing), Microbiology, Neurological Diseases, Pharmacogenomics, Cardiovascular Diseases, and Others. This report also provides key opportunities market and specific factors are given by each application market.
Market Insight by Technology
Here the market is fragmented into six parts; PCR, Transcription-Mediated Amplification (TMA), Hybridiazation (In-situ Hybridiazation & FISH), DNA Sequencing & NGS, Microarray and Others. Besides, many factors are analyzed that influence the growth, challenges and opportunities of market in technological context.
Market Insight by End User
The report provides complete insight of market by End User segments: Hospitals & Academic Laboratories, Clinics & Commercial Laboratories and Others. According to Renub Research Analysis, Hospitals & Academic Laboratories will hold the largest market in global molecular diagnostic test market in forecast period of time.
Market Insight by Regions
This report covers the complete regional profile by 10 geographical market; United States, Europe, India, China, Japan, Brazil, South Korea, Mexico, Russia and Rest of World (ROW).
By Application
• Infectious Diseases
• Blood Screening
• Oncology
• Genetic Testing
• HLA (Tissue Typing)
• Microbiology
• Cardiovascular Diseases
• Neurological Diseases
• Pharmacogenomics
• Others
Renub Research Infographics Zone: https://renubresearchinfographiczone.blogspot.com/
By Technology
• PCR
• Transcription-Mediated Amplification (TMA)
• Hybridiazation (In-situ Hybridiazation & FISH)
• DNA Sequencing & NGS
• Microarray
• Others
By End User
• Hospitals & Academic Laboratories
• Clinics & Commercial Laboratories
• Others
By Regions
• United States
• Europe (Expect Russia)
• India
• China
• Japan
• Brazil
• South Korea
• Mexico
• Russia
• Rest of World
If the information you seek is not included in the current scope of the study kindly share your specific requirements with our custom research team.
Browse Related Reports:
Contact Us
Email: info@renub.com
Phone: +1-678-302-0700
Web: www.renub.com
Key Topics Covered :
1. Executive Summary
2. Global Molecular Diagnostic Market
3. Market Share – Global Molecular Diagnostics
3.1 By Application
3.2 By Technology
3.3 By Countries
3.4 By Companies
4. Application – Molecular Diagnostics Market
4.1 Infectious Diseases
4.2 Blood Screening
4.3 Oncology / Cancer
4.4 Genetic Testing
4.5 HLA (Tissue Typing)
4.6 Microbiology
4.7 Cardiovascular Diseases
4.8 Neurological Diseases
4.9 Pharmacogenomics
4.10 Others
5. Technology – Molecular Diagnostics Market
5.1 PCR
5.2 Transcription-Mediated Amplification (TMA)
5.3 Hybridiazation (In-situ Hybridiazation & FISH)
5.4 DNA Sequencing & NGS
5.5 Microarray
5.6 Others
6. Region - Molecular Diagnostics Market
6.1 United States
6.2 Europe
6.3 India
6.4 China
6.5 Japan
6.6 Brazil
6.7 South Korea
6.8 Mexico
6.9 Russia
6.10 Rest of World (ROW)
7. End Users - Molecular Diagnostics Market
7.1 Hospitals & Academic Laboratories
7.2 Clinics and Commercial Laboratories
7.3 Others
8. Roche Diagnostics – Company Analysis
8.1 Merger & Acquisitions
8.2 Sales Analysis
9. Abbott Laboratories – Company Analysis
9.1 Merger & Acquisitions
9.2 Sales Analysis
10. Myriad Genetics – Company Analysis
10.1 Merger & Acquisitions
10.2 Sales Analysis
11. Qiagen – Company Analysis
11.1 Merger & Acquisitions
11.2 Sales Analysis
12. BioMérieux’s Inc – Company Analysis
12.1 Merger & Acquisitions
12.2 Sales Analysis
13. Market Drivers
13.1 Various Developments in the Molecular Diagnostics Landscape
13.2 Integral to Traditional Labs
13.3 Improved Assay / Test Efficiencies
13.4 Targeting Antibiotic Resistance
13.5 Next Generation Ultrasensitive Molecular Diagnostics
13.6 Increasing Investment in Genomics & Proteomics Research
13.7 Technological Advances in Molecular Diagnostics
13.8 Increasing Acceptance of the Personalized Medicine
13.9 Growing Molecular Diagnostics for Food Safety
14. Challenges
14.1 Dearth of Trained Professionals
14.2 Regulatory Issues
14.3 Various Factors Slowing Growth of Molecular Diagnostics
14.4 Reimbursement Capabilities
14.5 Quality Checkpoints, Awareness & Acceptance
About Us:
Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys, and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. Our clients rely on our market analysis and data to make informed knowledgeable decisions. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.
Media Contact
Company Name: Renub Research
Contact Person: Rajat Gupta
Email:Send Email
Phone: 16783020700
Address:225 Kristie Ln http://www.renub.com/
City: Roswell
State: GA
Country: United States
Website: www.renub.com/diagnostics-14-c.php
